These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 6161869

  • 1. Clinical implications of alpha-fetoprotein in liver cirrhosis: five-year follow-up study.
    Harada T, Shigeta K, Noda K, Fukumoto Y, Nishimura H, Mizuta M, Takemoto T.
    Hepatogastroenterology; 1980 Jun; 27(3):169-75. PubMed ID: 6161869
    [Abstract] [Full Text] [Related]

  • 2. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 3. Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver.
    Stránský J, Zichová M, Vodák M.
    Sb Lek; 1993 Oct; 94(4):311-5. PubMed ID: 7527585
    [Abstract] [Full Text] [Related]

  • 4. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.
    Scand J Gastroenterol; 2008 Oct; 43(7):849-56. PubMed ID: 18584524
    [Abstract] [Full Text] [Related]

  • 5. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL, Rosas-Camargo V, Vega-Vega O, Morales-Espinosa D, Mendez-Reguera A, Martínez-Tlahuel JL, Gamboa-Domínguez A, Arrieta O.
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El-Emshaty HM.
    Hepatogastroenterology; 2009 Apr; 56(94-95):1417-24. PubMed ID: 19950803
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA, Rendón Unceta P, Tejada Cabrera M, Infante Hernández JM, Correro Aguilar F, Díaz García F, Benítez Rodríguez E, Mangas Rojas A, Martín Herrera L.
    Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
    [Abstract] [Full Text] [Related]

  • 8. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
    Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takagi T, Toyota T, Takahashi T, Kasukawa R.
    Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
    [Abstract] [Full Text] [Related]

  • 9. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
    Huo TI, Hsia CY, Chu CJ, Huang YH, Lui WY, Wu JC, Lee PC, Chi CW, Lee SD.
    J Surg Oncol; 2007 Jun 15; 95(8):645-51. PubMed ID: 17530668
    [Abstract] [Full Text] [Related]

  • 10. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG, Mathews S, Jayanthi V, Shankar EM, Hari R, Surendran R, Vengatesan A, Raghuram K, Rajasambandam P, Murali A, Srinivas U, Palaniswamy KR, Pugazhendhi T, Thyagarajan SP.
    Int J Infect Dis; 2008 Nov 15; 12(6):e71-6. PubMed ID: 18658001
    [Abstract] [Full Text] [Related]

  • 11. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
    Peng YC, Chan CS, Chen GH.
    Hepatogastroenterology; 1999 Nov 15; 46(30):3208-11. PubMed ID: 10626187
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A, Carroccio A, Sesti R, Tripi S, Montalto G.
    Anticancer Res; 2003 Nov 15; 23(2C):1747-53. PubMed ID: 12820452
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis.
    Sterling RK, Jeffers L, Gordon F, Sherman M, Venook AP, Reddy KR, Satomura S, Schwartz ME.
    Am J Gastroenterol; 2007 Oct 15; 102(10):2196-205. PubMed ID: 17617202
    [Abstract] [Full Text] [Related]

  • 15. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W, Yao DF, Yuan YM, Fan JW, Lu XF, Li XH, Qiu LW, Zong L, Wu XH.
    Hepatobiliary Pancreat Dis Int; 2006 Nov 15; 5(4):538-44. PubMed ID: 17085339
    [Abstract] [Full Text] [Related]

  • 16. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
    Ganne-Carrié N, Chastang C, Chapel F, Munz C, Pateron D, Sibony M, Dény P, Trinchet JC, Callard P, Guettier C, Beaugrand M.
    Hepatology; 1996 May 15; 23(5):1112-8. PubMed ID: 8621142
    [Abstract] [Full Text] [Related]

  • 17. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A, Covino M, Caturelli E, Pompili M, Lorenzelli G, Villani MR, Valle D, Sperandeo M, Rapaccini GL, Gasbarrini G.
    Hepatogastroenterology; 2000 May 15; 47(36):1654-8. PubMed ID: 11149026
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study.
    McMahon BJ, Bulkow L, Harpster A, Snowball M, Lanier A, Sacco F, Dunaway E, Williams J.
    Hepatology; 2000 Oct 15; 32(4 Pt 1):842-6. PubMed ID: 11003632
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.